BackForma Therapeutics Holdings Overview

Forma Therapeutics Holdings Receivables

Forma Therapeutics Holdings's receivables is $15M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$15.37M
0.89% YoYΔ $136000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Forma Therapeutics Holdings Receivables History

Loading

Forma Therapeutics Holdings vs. peers: Receivables Comparison

Loading

Forma Therapeutics Holdings Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Forma Therapeutics Holdings (FMTX) FAQ

As of the most recent data (June 2022), FMTX shows a receivables of $15M. That compares with $15M in the prior-year period — up 0.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, FMTX's receivables is now $15M (was $15M) — a 0.9% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Forma Therapeutics Holdings is outperforming or lagging.

Tracking FMTX's receivables over time shows whether Forma Therapeutics Holdings is scaling, shrinking, or reshaping that part of the business. The current reading is $15M That compares with $15M in the prior-year period — up 0.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has Forma Therapeutics Holdings's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $15M) with ownership activity and broader fundamentals.

Forma Therapeutics Holdings's receivables is $15M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.